Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx zahraničních xxxx sděluje, že xxx 16. xxxxxxxxx 2007 xxxx generálním xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve sportu¹⁾, xxxxxxxx schválení xxxxxx xxxxx Přílohy I - Xxxxxxx zakázaných xxxxx x xxxxx dopingu.

Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. ledna 2008 x xxxxx xxxx vstoupila x xxxxxxxx x xxx Xxxxxx xxxxxxxxx. Dnem xxxxxx Xxxxxxx I x platnost xxxxxxxx xxxxxx Xxxxxxx I Xxxxxxxxxxx xxxxxx proti xxxxxxx xx xxxxxx xx xxxxx pro xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Xxxxxxx X x xxxx xxxxxxx xx xxxxxxx xxxxxx se xxxxxxxxx xxxxxxxx.

X1. ANABOLICKÉ LÁTKY

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (AAS):

x. Xxxxxxxx * XXX, zahrnující:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-androst-1-en-3,17-dion); xxxxxxxxx (19-norandrostendiol); bolasteron; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); dehydrochlormethyltestosteron (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; formebolon; furazabol (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); methylnortestosteron (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); methyltestosteron; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); norboleton; xxxxxxxxxxxxxx; xxxxxxxxxxxx; oxabolon; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; xxxxxxxxxx; xxxxxxxxx; 1-testosteron (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x xxxxx xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

b. Xxxxxxxxx ** AAS:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), xxxxxxxxxxx x xxxxxxxxxxx metabolity x isomery:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

androst-5-en-3β,17α-diol 19-norandrosteron

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, kdy může xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx xx mít xx xx, xx Xxxxxx xxxxxxxx xxxx Xxxxxxxxx xxxxx x xxxx hlášen xxxxxxxxx Xxxxxxxxx laboratorní xxxxx, xxxx xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx x/xxxx když xx jakýkoli jiný xxxxxxxxx xxxxx ve Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx xxxxxx, které xx xxxxxxxx xxxxxxxxx u xxxx xxx, že xxxxxxxxxx normální xxxxxxxxx xxxxxxxx. Xxxxxx se xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, pokud Xxxxxxxxx prokáže, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx nebo xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný xxxxx xx Xxxxxx Sportovce xxxxxxxx fyziologickým xxxx xxxxxxxxxxxx xxxxxx.

Bude xx xxx xx xx, xx Vzorek Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx a xxxxxxxxx xxxxxxx Pozitivní laboratorní xxxxx ve xxxxx xxxxxxxxx a xxx xxxxxxxxx xxxxxxxxxxx, xxxxx xxx xxxxx xxxxxxxxxx xxxxxxxxxx metody (např. XXXX) xxxxxxxx, xx xx Xxxxxxxx xxxxx xxxxxxxxxx původu. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx další xxxxxxx.

Xxxx xx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx látky, xxx xxxxxxxx známky xxxxxxx Xxxxxxxx látky, xxxx xxxx. xxxxxxxxx s xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, nebo xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx než xxxxx (4) xx xxxxx (1) x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ xxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx další xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxxxxxx testů.

Xx-xx vyžadováno xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx xxxx laboratoří xxxxxx xxxx xxxxxxxxx x xx xxxx xxxxxxxxx. Xxxxx laboratoř xxxxxxx, xx použití xxxxxxxxxx xxxxxxxxxx metody (xxxx. XXXX) exogenní xxxxx Xxxxxxxx xxxxx, xxxx nutné provádět xxxxx xxxxxxx, x xxxx xx mít xx xx, že Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Xxxxx nebyla xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx testy, bude xxxxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx xxx, xx xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx v následujících 3 xxxxxxxx xxxxxxx xxxxxxxx bez xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, bude hlášen xxxx xxxxxxxxx. Pokud xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx, xxxxxxxx následnými xxxxx, xxxx fyziologicky xxxxxxxx, xxxx xx xxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx.

X xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx může xxx x moči xxxxxx xxxxxxx boldenon endogenního xxxxxx xx xxxxxx xxxxxx xxxxxxxxxxxxx (ng/ml). Xxxxx laboratoř takový xxxxx nahlásila a xxxxxxx xxxxxxxxxx analytické xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx xxxxx, může xxx xxxxxxxxx další xxxxxxx provedením xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx nález 19-xxxxxxxxxxxxxxx, bude xx xx xxxxxxxxx xx xxxxxxx x přesvědčivý xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx látky. X xxxxxxx případě xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

X xxxxxxx, xx Sportovec nebude xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, bude se xxx xx xx, xx Vzorek Xxxxxxxxx xxxxxxxx Xxxxxxxxx látku.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Klenbuterol, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SARM), xxxxxxx, xxxxxxx, xxxxxxxxxx, xxx xx s xxxxxxxx xxxxx xx ně.

X2. XXXXXXX X PŘÍBUZNÉ XXXXX

Xxxxxxxxxxx látky x xxxxxx xxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxxxx (XXX);

2. Růstový xxxxxx (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), zakázané jen x mužů;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx xxxxxx prokázat, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, xx Vzorek xxxxxxxx Xxxxxxxxx látku (xxx xx xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx xx indikátorů x/xxxx příslušné xxxxxx xx Vzorku Sportovce xxxxxxx překročí hodnoty xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Pokud xxxxxxxxx xxxxxxxxx, xx xxxxx xxxxxxxxxx analytické xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx xx mít xx xx, že Xxxxxx obsahuje Xxxxxxxxx xxxxx x bude xxxxxxx Pozitivní laboratorní xxxxx.

S3. XXXX-2 AGONISTÉ

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx D- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, pro které xx xxx xxxxxxxx xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

I xxxx xxxx udělena xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, bude xxxxx xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx než 1000 xxxxxxxxx x 1 xxxxxxxxx xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, pokud Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx xxxxxxxx byl xxxxxxxx terapeutickým užíváním xxxxxxxxxxx x inhalaci.

X4. XXXXXXXXXXX X XXXXXXXXXX XXXXXXX

Xxxxxxxxxxx skupiny xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, zahrnující:

2. Selektivní xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SERM), xxxxxxxx:

3. Xxxxxxx antiestrogenní látky xxxxxxxxxx:

4. Xxxxx modifikující funkce xxxxxxxxxx včetně inhibitorů xxxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx ně.

X5. XXXXXXXXX A XXXXXXX XXXXXXXXX XXXXX

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Zahrnují:

Xxxxxxxxx*, xxxxxxxxxxxxxx, probenecid, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. albumin, dextran, xxxxxxxxxxxxxxxxx) x xxxxx xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, amilorid, xxxxxxxxx, xxxxxxxxx, chlortalidon, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (xxxx. bendroflumethiazid, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x další xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx (kromě xxxxxxxxxxxx, xxxxx není xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx xxxxxx, xxxxx moč Sportovce xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx xxxxxxxxxxx xxxxxxxx xxxx Xxxxxxxx látky (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Xxxxxxxx je xxxxxxxxxxx:

M2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

M3. XXXXXX XXXXXX

Neterapeutické xxxxxxx xxxxx, xxxx, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx xxxxxxx xxxx, xxxxx mají schopnost xxxxxx xxxxxxxxx xxxxx, xx xxxxxxxx.

X6. XXXXXXXXXXX

Všechna xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- a X-) xxxxxxx) xxxx xxxxxxxx, x výjimkou xxxxxxxx xxxxxxxxx x xxxxxxx xxxxxx místního xxxxx x xxxxxxxxxxx zahrnutých xx Monitorovacího xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, cyklazodon, xxxxxxxxxxxxxxxxx, efedrin****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxxxx, fenetylin, xxxxxxxxxxx, xxxxxxxxxxx, fenkamin, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, klobenzorex, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, meklofenoxát, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, norfenfluramin, oktopamin, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, strychnin, xxxxxxxxxxxxx x další xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx x xxxxx xxxxxx xxxx xxxxxxxxxx xx xxxxxxxxxxx xxxxx pouze, xxxxx Xxxxxxxxx prokáže, xx xxxx všeobecná dostupnost x xxxxxxx léčebných xxxxxxxxxxx umožňuje xxxxxxxxx xxxxxxxx antidopingových xxxxxxxx, xxxx xx x xxx xxxxx pravděpodobnost, xx bude xxxxxxx xxxxxxxx xxxx dopingová xxxxx.

S7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), fentanyl x xxxx deriváty, xxxxxxxxxxx, metadon, xxxxxx, xxxxxxxx, oxymorfon, pentazocin, xxxxxxx.

S8. XXXXXXXXXXX

Xxxxxxxxxxx (např. xxxxx, marihuana) jsou xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx xxxx nitrosvalovou xxxxxxxx xxxx xxxxxxxx. Xxxxxx xxxxx vyžaduje xxxxxxxxxxxxx xxxxxxx.

Jiné xxxxxxx injekční aplikace (xxxxxxxxxxxx, xx xxxxx xxxxxx, xx xxxxx xxxxxx, epidurální, xx xxxx) x xxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx s xxxxxxxx xxxx uvedených.

Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx kožní (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), ušní, xxxxx, oční, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx a xxxxx nejsou xxxxxxxx x nevyžadují xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

X1. XXXXXXX

Xxxxxxx (etanol) xx zakázaný pouze Xxx xxxxxxx v xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx provádět xxxxxxxx zkouškou a/nebo xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) je xxx xxxxxx federaci xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx x parašutismus (XXX) (0.20 x/x)

∙ Lukostřelba (FITA, XXX) (0.10 g/l)

∙ Xxxxxxx pětiboj (XXXX) xxx xxx xxxxxxxxxx xx střelbou (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 x/x)

∙ Kuželky (IPC) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Při xxxxxxx x následujících xxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX)

∙ Billiard (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Xxxxxxx xxxxxx a parašutismus (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxxxxx (FIS) - xxxxx na xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx a X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx xxx"

∙ Moderní xxxxxxx (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, XXX "bowls")

∙ Střelba (XXXX, XXX) (xxxxxxxx také Xxxx soutěž)

∙ Xxxxx xxxxxxxxxx (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, betaxolol, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, xxxxxxxxxxxx, metoprolol, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, timolol, xxx ne x xxxxxxxx xxxxx na xx

"Xxxxxxxxxx xxxxx"* xxxx xxxxxxxxxxx xxxx:

∙ Všichni Beta-2 xxxxxxxx x inhalaci, xxxxx salbutamolu (xxxxxxx xxxx xxxxxxxxxxx) xxx xxxxxxxx xxxxxx xxx 1000 xx/xx moči x xxxxxxxxxxxx (zařazen xx xxxxxxx S 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, haptaminol, isomethepten, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, niketamid, norfenefrin, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx v xxxxxx X6, pro xxxxx Xxxxxxxxx xxxxxxx, že xxxxxxx xxxxxxxx popsané x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Seznamu xxxxx být xxxxxxxxxxx xxxxxxxxxx látky, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx xxxxxxxxx xxxxxxxx x xxxxxxx xxxxxxxxx přípravcích, nebo x xxxxx xx xxxxx pravděpodobnost, že xxxxx úspěšně xxxxxxxx xxxx dopingová činidla." Xxxxxxxx xxxxxxxxxxxxxxx pravidla xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx předpokladu, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, že Xxxxxxx xxxxxxxxxx xxxxx xxxxxx xxxxxxxxx xx xxxxxxx sportovního xxxxxx...".

Xxxxxx xxxxxxx č. 2/2008 Sb. x. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx předpis x. 2/2008 Sb. x. x. byl xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx od 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x odkazech není xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx předpisu.